Skip to main content
. 2022 Sep 14;415(6):1033–1063. doi: 10.1007/s00216-022-04320-z

Table 2.

Examples of biomarkers involved in neurological disorders. Adapted after [84]

Biomarker Physiological implications Pathological effect Disorder
Amyloid beta Lipid homeostasis, memory formation, regulation of synaptic activity, neural viability Oxidative stress, synaptic dysfunction, inflammation, apoptosis, neurite damage Alzheimer’s disease
Tau protein Promotes microtubules polymerization, stability, and flexibility Neuronal damage, pro-apoptotic Alzheimer’s disease, Parkinson’s disease
Alpha-synuclein Intervenes in the release of neurotransmitters, modulates DNA repair processes Synaptic and mitochondrial dysfunctions, oxidative stress, dysregulation of calcium signaling, microtubule impairment Parkinson’s disease
Chromogranin A Vasoconstriction, regulation of glucose metabolism and storage, modulator of the neuroendocrine system Oxidative stress, inflammation, neuronal damage Amyotrophic lateral sclerosis
Micro-RNAs Nervous system development and function Microglial activation, increase of proinflammatory cytokine release, and neuron loss Autist spectrum disorders